8,517 articles
Andrew G. Engel
Andrew G. Engel (1930–2024) was a Hungarian-born American neurologist and neuroscientist at the Mayo Clinic in Rochester, Minnesota, and a pioneer in neuromuscular diseases, elected in 2003 to the Institute of Medicine.
ANDREW G. FRANTZ
Andrew G. Frantz (died 2010) was an American endocrinologist at Columbia University best known for showing that human prolactin is a hormone separate from growth hormone.
Andrew G. Morrow
Andrew G. Morrow was an American cardiac surgeon who led surgery at the National Heart Institute in Bethesda and created the septal myectomy operation for obstructive hypertrophic cardiomyopathy.
Andrew G. Plaut
Andrew G. Plaut is a physician-scientist and Professor of Medicine at Tufts in Boston, known for discovering bacterial IgA proteases and developing them to treat IgA nephropathy.
Andrew G. Renehan
Andrew G. Renehan is a British colorectal surgeon-scientist, Professor of Cancer Studies and Surgery at the University of Manchester, known for research linking obesity, diabetes, and cancer risk.
Andrew H. Limper
Andrew H. Limper is a pulmonary and critical care physician-scientist at Mayo Clinic in Rochester, Minnesota, where he has researched Pneumocystis pneumonia and pulmonary fibrosis since the 1980s.
Andrew H. Soll
Andrew H. Soll is an American physician-scientist in gastric physiology and acid-peptic disease, known for work on how the stomach secretes acid and how peptic ulcers form and heal.
Andrew H. Wei
Andrew H. Wei is an Australian clinical haematologist and laboratory head at WEHI in Melbourne whose trials and venetoclax research reshaped treatment of acute myeloid leukemia.
Andrew Haines
Andrew (Andy) Haines is a physician and epidemiologist who helped found climate change and health research, and directed the London School of Hygiene & Tropical Medicine from 2001 to 2010.
Andrew Hattersley
Andrew Hattersley is a British clinical scientist in diabetes genetics at the University of Exeter, known for showing neonatal diabetes can be treated with tablets instead of insulin.
Andrew I. Schafer
Andrew I. Schafer is an American hematologist-oncologist known for research on thrombosis and platelet function, the widely cited 2004 NEJM review "Thrombocytosis," and leadership of hematology departments at Baylor, Penn, and Weill Cornell.
Andrew J. Dannenberg
Andrew J. Dannenberg is an American physician-scientist at Weill Cornell Medicine who established COX-2 as a target for cancer prevention; in 2023 the Office of Research Integrity found misconduct.
Andrew J. Lees
Andrew J. Lees (Andrew Lees) is a British neurologist at University College London who has spent his career on Parkinson's disease and atypical parkinsonian disorders.
Andrew J. Prendergast
Andrew J. Prendergast is a pediatric infection researcher and Wellcome Trust Senior Clinical Fellow at Queen Mary University of London who studies HIV and child malnutrition.
Andrew J. Tatem
Andrew J. Tatem is a professor of spatial demography and epidemiology at the University of Southampton who founded WorldPop, producing open population maps used by governments and UN agencies.
Andrew J.M. Boulton
Andrew J.M. Boulton is a British diabetologist, Professor of Medicine at the University of Manchester, known for research on diabetic neuropathy and diabetic foot disease.
Andrew J.S. Coats
Andrew J.S. Coats, also known as Andrew Coats, is an Australian-born cardiologist and heart-failure researcher, now Scientific Director and CEO of the Heart Research Institute in Sydney.
Andrew K. Burroughs
Andrew K. Burroughs, also known as Andrew Burroughs, was a British hepatologist and professor at University College London who spent 35 years at the Royal Free Hospital's liver center.
Andrew L. Warshaw
Andrew L. Warshaw is an American pancreatic surgeon and researcher at Massachusetts General Hospital, its Surgeon-in-Chief, Emeritus, and a Harvard Medical School professor known for pancreatic cancer research.
Andrew L. Wit
Andrew L. Wit is a cardiac electrophysiologist and Emeritus Professor of Pharmacology at Columbia University, known for experimental work on reentrant ventricular tachycardia after myocardial infarction.
Andrew P. Goldberg
Andrew P. Goldberg (1945–2022) was an American physician-scientist in geriatric medicine who led geriatrics at the University of Maryland and founded the Baltimore VA GRECC.
Andrew P. Selwyn
Andrew P. Selwyn is a cardiologist and physician-scientist at Brigham and Women's Hospital and Harvard Medical School in Boston, now Professor of Medicine, Emeritus, known for work on coronary blood flow in atherosclerosis.
Andrew P. Waters
Andrew P. Waters is a molecular parasitologist and professor at the University of Glasgow who pioneered genetic tools for the rodent malaria parasite Plasmodium berghei.
Andrew R. Marks
Andrew R. Marks is an American cardiologist and molecular physiologist at Columbia University whose laboratory showed that leaky ryanodine receptor calcium channels drive heart failure and arrhythmias.
Andrew R. Willan
Andrew R. Willan is a Canadian biostatistician, Professor Emeritus at McMaster University, known for cost-effectiveness analysis of randomized trial data and value of information methods in trial design.
Andrew Rambaut
Andrew Rambaut is an evolutionary biologist at the University of Edinburgh who studies the evolution and epidemiology of RNA viruses including HIV, Ebola, and SARS-CoV-2, and develops the BEAST software.
Andrew Rhodes
Andrew Rhodes is a British consultant and professor of intensive care medicine and anesthesia at St George's University Hospitals in London, co-chair of the Surviving Sepsis Campaign.
Andrew S. Levey
Andrew S. Levey is an American nephrologist at Tufts Medical Center known for developing the MDRD and CKD-EPI equations that estimate kidney function from routine blood tests.
Andrew Saxon
Andrew Saxon is an American allergist-immunologist who led UCLA's clinical immunology division for nearly 30 years and developed bifunctional fusion proteins that inhibit IgE-mediated allergic reactions.
Andrew Singleton
Andrew Singleton is an American neurogeneticist who spent 2001 to 2025 at the National Institutes of Health, discovered LRRK2 and alpha-synuclein mutations in Parkinson's disease, and now co-leads GP2.